DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Jennifer Kates - 2 Brian Snyder - 1 Ali Mokdad - 1 Mokdad - 1 Irfan Khan - 1 Brad Pollock - 1 Nicole Iovine - 1 epidemiologist - 1
Top related locs:
Somerville , Massachusetts U.S Novavax Covid Eagle Rock , California
Top related orgs:
Pfizer - 2 Moderna - 2 Walgreens - 1 Centers for Disease Control - 1 CDC - 1 University of Washington - 1 CVS Pharmacy - 1 Los Angeles Times - 1

Search resuls for: "Jennifer Kates"


3 mentions found


☆ Covid vaccine rates in the U.S. are slumping — and it will be a challenge to boost them
  + stars: | 2023-11-30 | by ( Annika Kim Constantino | ) www.cnbc.com   time to read: +10 min
In this article PFEMRNANVAX Follow your favorite stocks CREATE FREE ACCOUNTA sign advertises Covid vaccine shots at a Walgreens Pharmacy in Somerville, Massachusetts, on Aug. 14, 2023. Brian Snyder | ReutersThree years into the Covid-19 pandemic, few Americans are rolling up their sleeves to get a Covid vaccine. Experts and vaccine makers can agree that low Covid vaccination rates are concerning, even as cases of the virus dwindle from their pandemic highs. However, Iovine of the University of Florida doesn't believe combination shots will have a significant effect on Covid vaccination rates. If combination shots don't do the trick, it's unclear what else could boost Covid vaccination rates down the line.
Persons: Brian Snyder, Ali Mokdad, Mokdad, Irfan Khan, Jennifer Kates, Brad Pollock, Nicole Iovine, epidemiologist, Iovine, Michael Yee, Albert Bourla, Arpa Garay, Garay, John Trizzino, Trizzino, Jamey Mock, Andrew Pekosz, Jefferies, Yee, doesn't Organizations: Walgreens, Reuters, Pfizer, Moderna, Centers for Disease Control, CDC, University of Washington, CVS Pharmacy, Los Angeles Times, KFF, UC Davis Health's, University of Florida, Jefferies, Arpa, CNBC, Istock, Getty, Johns Hopkins Bloomberg School of Public Health Locations: Somerville , Massachusetts, U.S, Novavax, Covid, Eagle Rock , California
☆ FDA Approval of New COVID Boosters Could Come by Friday
  + stars: | 2023-09-07 | by ( Sept. | At A.M. | ) www.usnews.com   time to read: +2 min
Sources familiar with U.S. Food and Drug Administration plans say boosters could be approved as soon as Friday, NBC News reported. This time, the FDA may grant full approval for the boosters rather than emergency use authorization, according to NBC News sources. If the FDA doesn’t approve the boosters on Friday, it could do so early next week. While protection wanes over time, about 97% of adults have some level of protective immunity from past COVID infections and vaccinations. The Biden administration has announced a “bridge” program to offer uninsured people access to free boosters through 2024.
Persons: Cara Murez HealthDay, Mandy Cohen, Jennifer Kates, Biden, Kates Organizations: U.S . Food, Drug Administration, NBC News, U.S . Centers for Disease Control, Prevention, Pfizer, Moderna, NBC, Global Health, HIV
☆ Another major HIV vaccine trial fails
  + stars: | 2023-01-18 | by ( Benjamin Ryan | Https | Media-Cldnry.S-Nbcnews.Com Image Upload Newscms Matt-Lavietes-Byline-Jm.Jpg | ) www.nbcnews.com   time to read: +8 min
The only HIV vaccine in a late-stage trial has failed, researchers announced Wednesday, dealing a significant blow to the effort to control the global HIV epidemic and adding to a decadeslong roster of failed attempts. “I don’t think that people should give up on the field of the HIV vaccine,” Fauci said. Fauci said that a critical limitation of the Mosaico vaccine was that it elicited what are known as non-neutralizing — as opposed to neutralizing — antibodies against HIV. As with the Thai trial, the hope is to channel research findings into future HIV vaccine development. To prove a vaccine works, researchers must recruit participants who remain at substantial risk of HIV over time.
0 next >>
Total: 3